Concurrently, studies on mammalian bombesin (Bn)‐related peptides and their receptors in CNS tumors are uncovering unique molecular regulatory networks, presenting novel therapeutic opportunities when integrated with GBM niche dynamics. This evidence concerns the gene GRP and central nervous system neoplasm.